GAITHERSBURG, Md., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company's senior management team will participate in the following investor conferences during the first quarter of 2017.
35 Annual J.P. Morgan Healthcare Conference San Francisco, CA
January 9-12, 2017
Presentation: January 10, 2017
Wells Fargo Specialty and Generic Drug Summit Orlando, FL
February 13, 2017
Presentation time TBD
Cowen & Co. 37 Annual Health Care Conference Boston, MA
March 6-8, 2017
Presentation day and time TBD
Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under 'Investors' as this information becomes available.
Top Company Interviews
For these conferences, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.
About Emergent BioSolutions
Emergent BioSolutions is a global specialty biopharmaceutical company dedicated to one simple mission-to protect and enhance life. We develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Follow us @emergentbiosolu.
Robert G. Burrows
Vice President, Investor Relations
Tracey Schmitt Lintott
Senior Vice President, Global Public Affairs
Emergent BioSolutions Inc.
Emergent BioSolutions Inc. published this content on 29 December 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 December 2016 21:22:05 UTC.